July, 2020

article thumbnail

Merck nears clinical tests for coronavirus vaccine candidates

Bio Pharma Dive

Two candidates recently acquired in deals with IAVI and Themis have shown promise in preclinical studies, Merck executives said, and Phase 1 trials will begin later this year.

Vaccine 284
article thumbnail

Ten pharma digital marketing facts

World of DTC Marketing

QUICK READ: A reporter for a leading business magazine recently reached out to me and asked “what are Pharma product websites so bad?” OK, maybe not all of them are that bad but I would bet that 80% are really poor. There is a lot of blame to go around but these facts are still relevant today. 1ne: There is a direct correlation between time on site and asking for/about your product.

Marketing 183
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Preclinical and Nonclinical Studies— What Is the Difference, and Where in Your Program Should They Fall?

Camargo

Have you ever wondered about the difference between preclinical and nonclinical studies? While those in. The post Preclinical and Nonclinical Studies— What Is the Difference, and Where in Your Program Should They Fall? appeared first on Camargo.

149
149
article thumbnail

MHRA OKs Celltrion's Phase I trial of COVID drug

Pharma Times

The trial will enrol patients with mild symptoms of SARS-CoV-2 infection to evaluate the safety, tolerability, efficacy, pharmacokinetics and immunogenicity of CT-P59

Trials 142
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Pharmapack Moves to May 2021

Pharma Mirror

Pharmapack Europe (#pharmapackeu), organised by Informa Markets, moves to May 2021 (19-20) to provide attendees, exhibitors and the pharma packaging community the best season and format. The decision follows a careful review with key stakeholders, with the exhibition continuing at its usual location: Hall 7.2 at Paris Expo, Porte de Versailles. By announcing the rescheduling.

article thumbnail

Survey: Gen Z’ers Want to Eat More Plant-Based and Vegan Foods

XTalks

Gen Z is setting food trends in the post-pandemic world, The Food Institute reports, and their food choices include: Ordering in more, choosing frozen foods and eating more plant-based meals. They believe you don’t have to be vegan to want to eat more vegan foods, the Institute report noted, in a review of how these young consumers are influencing food trends.

Protein 116

More Trending

article thumbnail

Pharma wasting money on digital ads

World of DTC Marketing

QUICK READ: Pharma digital agencies are doing their clients a huge disservice by recommending heavy paid search. The reality is that the ROI for most paid search is very low. If the growing cost of digital advertising were matched by commensurate sales growth, then higher digital ad spend would pose no problem. But the reality is quite different: While digital spending is becoming more expensive, it is generally not becoming more effective. .

Marketing 148
article thumbnail

A 505(b)(2) Primer: Building the Bridge Between an Approved Drug and Your Novel Therapy

Camargo

This blog features considerations and recommendations for sponsors exploring a 505(b)(2) pathway to drug approval. The post A 505(b)(2) Primer: Building the Bridge Between an Approved Drug and Your Novel Therapy appeared first on Camargo.

Drugs 132
article thumbnail

UK firm starts research on skin patch for COVID vaccines

Pharma Times

The patch will be tested to deliver a vaccine dose via the skin, as well as achieve a simple and secure disposal process to enable at-home use.

article thumbnail

Softbox announces the appointment of new global CFO

Pharma Mirror

Softbox, a leading global innovator and provider of temperature control packaging systems and thermal covers for the life science and logistics industries, has announced the appointment of Charlie Nicholson as Softbox’s new Global CFO. Reporting directly to Kevin Valentine, CEO of Softbox, Charlie Nicholson joins the leadership team and is responsible for all financial and.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Could Soil-Free Farming Prevent Future Food Insecurity?

XTalks

Soil-free, computer-controlled farms could offer a solution for future crop growing as climate change and soil erosion limit farmers’ ability to grow, according to new research. The research , published in New Phytologist and led by scientists at the University of Bristol, John Innes Centre and LettUs Grow, describe the growing environmental and economic case for vertical farming methods which could see crops grown in previously unfarmable environments such as the deserts of Dubai to count

Research 105
article thumbnail

Lonza: the right bio model can make a difference

Outsourcing Pharma

A leader from the health solutions and technology company explains how the proper biological models can enhance drug discovery and development.

article thumbnail

Digital metrics that count

World of DTC Marketing

QUICK READ : Pharma seems to be making great progress in the use of digital marketing to reach HCP’s but when it comes to consumers they still rate near the bottom. Not only does pharma spend too much on paid media, without adequate measurement, but they also don’t invest enough in their product website development and testing. Attention on the Internet is at a premium, even for online health seekers.

Branding 131
article thumbnail

Multidisciplinary Team Advances Immuno-Oncology Development

Camargo

The post Multidisciplinary Team Advances Immuno-Oncology Development appeared first on Camargo.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

US expands scope of Janssen's Stelara

Pharma Times

The new approval cover paediatric patients with plaque psoriasis

104
104
article thumbnail

Made-in-Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials

Pharma Mirror

First dose of ETC-159 administered in Phase 1B of clinical trials, advancing the development of this drug to treat solid tumours Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving “First Patient First Visit[1]” in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of.

article thumbnail

Are All Excipients Truly Inert? Maybe Not, Suggests New Study

XTalks

For decades, formulation scientists have relied on the assumption that common pharmaceutical excipients are biologically inert. Now, results from a new study conducted by researchers at the UC San Francisco (UCSF) School of Pharmacy and the Novartis Institutes for BioMedical Research (NIBR), have challenged drugmakers’ understanding of the effects of excipients.

Protein 103
article thumbnail

World Courier: COVID-19 impacting trial supply chain

Outsourcing Pharma

A leader from the specialty logistics firm discusses how the clinical researching industry is shifting, thanks in large part to the pandemic, and how to prepare for the future.

Trials 101
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

COVID-19 vaccine: A hope and prayer?

World of DTC Marketing

QUICK READ : The government is agreeing to pay billions of dollars to the first company that developed a COVID-19 vaccine. We would like to think that any vaccine development will be within GMP and the drug approval process guidelines but when billions of dollars are at stake will the industry cut corners and who is going to be the watchdog? U.S. health officials agreed to pay $1.95 billion for 100 million doses of a vaccine made by Pfizer Inc. and BioNTech SE, the latest step in an effort to fi

article thumbnail

Multidisciplinary Team Advances Immuno-Oncology Development

Camargo

The post Multidisciplinary Team Advances Immuno-Oncology Development appeared first on Camargo.

article thumbnail

Kodak C.E.O. Got Stock Options Day Before News of Loan Sent Stock Soaring

NY Times

The stock options suddenly were worth about $50 million — the latest instance of extraordinary good timing by corporate executives.

98
article thumbnail

How to Know If your Toddler Has Tooth Decay and How to Reverse It?

Pharma Mirror

What is a toddler tooth decay? Do you have children in your house? Then you must face the problem of dental cavities and tooth decay and have to deal with these as well. Usually, the decay of the tooth is a breakdown or destruction of tooth enamel. We all know the fact that enamel is. The post How to Know If your Toddler Has Tooth Decay and How to Reverse It?

130
130
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

6 Key Takeaways from HBA’s “Virtual Best Practices: Clarity, Collaboration and Connecting”

Pharma Marketing Network

Recently, the Healthcare Businesswomen’s Association (HBA) held a webinar entitled, Virtual Best Practices: Clarity, Collaboration and Connecting , which dove into the topic of “Zoom fatigue,” a new, commonly used term defined by the draining feeling you experience after a day of long, unnecessary meetings. We are all facing new challenges in the rapidly changing work environment.

article thumbnail

Parexel: improving trial diversity can elevate outcomes

Outsourcing Pharma

A representative from the pharma services firm discusses how increasing diversity of clinical trial populations can improve research effectiveness.

Trials 100
article thumbnail

Launching a drug in a pandemic

World of DTC Marketing

QUICK READ : Prescribers are reviewing some of their favorite prescribed drugs and are open to learning about new drugs in terms of efficacy and patient outcomes but you had better be ready to talk about patients beyond the science. Some may think it’s a bad time to be launching a drug but actually the reverse may be true. Doctors who don’t work in hospitals have the time to engage with drug MLS people virtually and a lot of them are reviewing the drugs that “they tend to presc

Drugs 130
article thumbnail

Good Gut Bacteria Can Aid in Healing Intestines Damaged by IBD

XTalks

A study published in Nature on July 30, 2020 states that good bacteria living in our gut can do much more than just help digest food and boost our immune system. According to studies conducted by researchers at Cincinnati Children’s Hospital, the bacteria can help heal damaged intestinal tissues. The findings show that the bacteria in the intestine can help repair tissue damage among patients with inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine

NY Times

Well-timed stock bets have generated big profits for senior executives and board members at companies developing vaccines and treatments.

article thumbnail

PCRS releases new guidance on diagnosis of respiratory conditions during COVID

Pharma Mirror

The Primary Care Respiratory Society (PCRS) has issued a position statement and recommendations for clinicians on the diagnostic work up of patients presenting with respiratory symptoms while Covid-19 remains in active circulation. The recommendations bring together the cross-functional experience of PCRS members on the safest and most appropriate approach when evaluating patients presenting with respiratory.

130
130
article thumbnail

Ultimate Guide To Clinical Trial Costs

Clinical Trial Podcast

Have you been tasked to develop a clinical trial budget? Well, you’re in luck because I’m going to share everything you need to know about clinical trial costs. Clinical trial budgets are often put together in haste. The focus is on getting the product to market as quickly as possible. Or revenues and profits. Developing a clinical trial budget can be a confusing exercise for sponsors and CROs.

article thumbnail

Ensuring process consistency and cost effectiveness with AIM 3000

Syntegon Technology Pharma Blog

96
article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.